What's new

CoronaVirus in US - Updates & Discussion

another Chinese with fake Pakistani ID

bringing race into thread reported
Interesting - why is this fellow obsessed with US numbers - i guess nothing better to do
 
.
Insulted Other Member/Nationality
....
 
Last edited by a moderator:
.
.
ja GHQ meh ja kar shikayat kar
bol sab ko kis tara meh kisee pakistani kee nakal kar raha hoo



Your 100% dutch/boer and probably a european (ashkenazi) jew yet being the subversive types you went around claiming how your not white. even if that were true you are very much a privileged boer.


so what if i am 'in league'? you make it sound like its a conspiracy LOL
lol sry bra but i don't think you have your divine granted right to go around telling people their place and position like most judaics think they do.
REported for abuse of race, religion, family.
 
.
ja GHQ meh ja kar shikayat kar
bol sab ko kis tara meh kisee pakistani kee nakal kar raha hoo



Your 100% dutch/boer and probably a european (ashkenazi) jew yet being the subversive types you went around claiming how your not white. even if that were true you are very much a privileged boer.


so what if i am 'in league'? you make it sound like its a conspiracy LOL
lol sry bra but i don't think you have your divine granted right to go around telling people their place and position like most judaics think they do.

another fake Pakistani with Chinese ID
 
.
another fake Pakistani with Chinese ID
Austin loves to post about US..

Why does he not post about the censorship of COVID in CHina.

Posting latest videos from Wuhan from early days.

 
.
In Feb. 2021, blood work showed I had Covid antibodies. And a few days ago, another blood work showed I still have pretty high level of Covid antibodies: 179 units/uL when only 8 units would have been enough to make it Positive.
I am NOT going to take a vaccine in light of my existing level of antibodies unless travel requirements force me to. I believe I am on the side of science but have faced attacks from some now estranged friends over the last one year.
 
.
When the trolls failed in their attempt to slender China, they will apply words like my Ministry of Propaganda meaning Singapore example Singapore Virus.

:omghaha: :omghaha: :omghaha:

BBC journalist George MacCarthy proves that the Virus is from Wuhan with dateline and
how USA cases went from 1 case to million in record time as though it was there before anyone heard of it.

:coffee: :sarcastic:


Everyone should watch this. It is very funny.

The trolls are jumping up and down.

:omghaha: :omghaha: :omghaha:
 
. .
stop trolling.with your stupid videos.
:sarcastic::sarcastic::sarcastic:

Why not just let the other more intelligent folks in here decide whether it is a stupid video or not?

Why are you so scare that other gets to watch this video?

Is it offensive to your race, religion or just a case of your slendering of China just got debunked as well.

Not unless it is case of you acknowledging that you are just a childish troll in here.

:cheers:
 
Last edited:
.
Wuhan Laboratory is a WHO cerified BSL-4 laboratory, the highest in safety standard in the world.
What is Fort Detrick Military Laboratory safety standard?
Probably NONE because USA won't allowed any WHO inspectors in there.


Wuhan Institute of Virology lab director refutes WSJ report on sick staff, calling US intelligence doc 'a complete lie'
By
Chen Qingqing
Published: May 24, 2021 12:51 PM

Wuhan Institute of Virology file photo:VCG

Wuhan Institute of Virology file photo:VCG
The so-called US intelligence report on sick staff at the Wuhan Institute of Virology is an outright lie that came from nowhere, Yuan Zhiming, director of the institute's Wuhan National Biosafety Laboratory, told the Global Times on Monday, refuting the latest report from the Wall Street Journal about an undisclosed US intelligence report indicating three researchers from the lab became sick in November 2019.

"I've read it, it's a complete lie," Yuan said when he was asked by the Global Times on Monday morning about the WSJ story, which was published on Sunday titled "Intelligence on Sick Staff at Wuhan Lab Fuels Debate on COVID-19 Origin".

The story, citing an unpublished report that was issued during the final days of the Trump administration, said several researchers at the lab became sick in the autumn of 2019 with symptoms consistent with both COVID-19 and common seasonal illnesses.

"Those claims are groundless. The lab has not been aware of this situation [sick researchers in autumn 2019], and I don't even know where such information came from," the Chinese researcher told the Global Times.

WSJ published the story on the eve of the World Health Assembly, which is expected to discuss the next phase of the research into COVID-19's origins, the US media report said.

US politicians and media outlets have again been pursuing the lab leak theory as the origin of COVID-19, despite scientists from the WHO-China joint study team concluding in a full report after field study in Wuhan that a lab leak is extremely unlikely.

The lab leak theory was a baseless argument from the beginning, which is the consensus of global scientists, according to experts from the joint team.

The report, generated in March after WHO experts visited Wuhan, suggested COVID-19 came about from transmissions between animals and humans, and transmissions through frozen food
 
.
Why is USA so afraid of Chinese vaccines?
:coffee:

It is the same story at the same place and yet the reports by CNN (US Press) and
Jakarta Globe (Indonesia Press) can so different.
Of course, Jakarta Globe report is more accurate in this case.

Is this BIDEN's latest $1.2b Propaganda News Media war budget against China using fake news and false narratives.

https://edition.cnn.com/2021/06/18/asia/vaccinated-indonesian-doctors-covid-19-intl-hnk/index.html


https://jakartaglobe.id/news/sinova...workers-from-severe-covid19-in-deltahit-kudus

Jakarta. Most of the 308 health workers vaccinated with Sinovac's Coronavac vaccine in Kudus, Central Java, a district recently hit hard by the novel coronavirus Delta variant, recovered from the disease last week, an encouraging indication of how the Chinese-made vaccine fare against the more infectious variant.

Badai Ismoyo, the Kudus district health department head, said administering the Covid-19 vaccine to health workers in the local area has proven effective in protecting them from the worst conditions.

"Today, 90 percent of health workers who are self-isolating can return to work and return to serving the community," Badai said in a statement on Friday.

"This is encouraging news. In addition, it also shows that the vaccine given to them is really effective in protecting against the worst conditions," he said.

As of June 12, 308 health workers in Kudus were tested positive for Covid-19 after treating patients with the disease in the region.

The Covid-19 spread in Kudus was rapid and massive, leading health officials to suspect that a new, more infectious virus variant had come to the region brought by Indonesian migrant workers returning from abroad.

A gene sequencing by the Gajah Mada University in Yogyakarta confirmed the suspicion. The university conducted gene sequencing on 34 virus samples from the district last week, finding 28 of them were of the Delta variant, a SARS-CoV-2 mutation first detected in India.

Still, the health officials take confidence in the limited spread of the virus among vaccinated health workers and the speedy recovery of those two who contracted the virus.

Badai said most of the health workers in the region received the Covid-19 vaccine during the government's vaccination program from January to March.

Kudus district used the Sinovac Covavac vaccine, which so far still accounts for more than 89 percent of Indonesia's vaccine supply.

As of June 17, 6,085 health workers and health support personnel in Kudus had been vaccinated with the first dose, and 5,888 people had received the second dose.

“Almost 100 percent of the health workers in Kudus, amounting to around 6,000 people, have received the first and second doses of vaccination," Badai said.

"Of this number, only 308 health workers were exposed or around 5.1 percent of the total number of health workers. Most of them have recovered and have started working again," he said.

Abdul Aziz Achyar, the director of Kudus's dr. Loekmono Hadi Regional General Hospital, said a total of 153 health workers at the hospital confirmed to have Covid-19. Only 11 people, or 7.1 percent, needed hospitalization. The other 86 (56 percent) used to be in self-isolation but now ready to work, following the rest of their colleagues who had recovered earlier.

The government's vaccination program focused on immunizing health workers first, before vaccinating workers in the services industry, civil servants, and the elderly. The government will start nationwide vaccination for the general population next month, although several provinces, like Jakarta, had done so last week.

In an attempt to stem the Covid-19 spike in Kudus, the Ministry of Health has dropped 50,000 doses of the Covid-19 vaccine to accelerate vaccination coverage in the region.

"For now, we have intensified mass vaccinations in Kudus so that later we can slow down the transmission of Covid-19," H.M. Hartopo, Kudus district head, said.

Hartopo said the spike in Covid-19 cases started with homecomers returning to Kudus.

"We need to inform people that people should not ignore health protocols even though they have been vaccinated. The vaccination itself is actually only a means of increasing immunity. So that if exposed to Covid-19, there are no severe symptoms," he said.
 
Last edited:
.
Why is USA so afraid of Chinese vaccines?
:coffee:

It is the same story at the same place and yet the reports by CNN (US Press) and
Jakarta Globe (Indonesia Press) can so different.
Of course, Jakarta Globe report is more accurate in this case.

Is this BIDEN's latest $1.2b Propaganda News Media war budget against China using fake news and false narratives.

https://edition.cnn.com/2021/06/18/asia/vaccinated-indonesian-doctors-covid-19-intl-hnk/index.html


https://jakartaglobe.id/news/sinova...workers-from-severe-covid19-in-deltahit-kudus

Jakarta. Most of the 308 health workers vaccinated with Sinovac's Coronavac vaccine in Kudus, Central Java, a district recently hit hard by the novel coronavirus Delta variant, recovered from the disease last week, an encouraging indication of how the Chinese-made vaccine fare against the more infectious variant.

Badai Ismoyo, the Kudus district health department head, said administering the Covid-19 vaccine to health workers in the local area has proven effective in protecting them from the worst conditions.

"Today, 90 percent of health workers who are self-isolating can return to work and return to serving the community," Badai said in a statement on Friday.

"This is encouraging news. In addition, it also shows that the vaccine given to them is really effective in protecting against the worst conditions," he said.

As of June 12, 308 health workers in Kudus were tested positive for Covid-19 after treating patients with the disease in the region.

The Covid-19 spread in Kudus was rapid and massive, leading health officials to suspect that a new, more infectious virus variant had come to the region brought by Indonesian migrant workers returning from abroad.

A gene sequencing by the Gajah Mada University in Yogyakarta confirmed the suspicion. The university conducted gene sequencing on 34 virus samples from the district last week, finding 28 of them were of the Delta variant, a SARS-CoV-2 mutation first detected in India.

Still, the health officials take confidence in the limited spread of the virus among vaccinated health workers and the speedy recovery of those two who contracted the virus.

Badai said most of the health workers in the region received the Covid-19 vaccine during the government's vaccination program from January to March.

Kudus district used the Sinovac Covavac vaccine, which so far still accounts for more than 89 percent of Indonesia's vaccine supply.

As of June 17, 6,085 health workers and health support personnel in Kudus had been vaccinated with the first dose, and 5,888 people had received the second dose.

“Almost 100 percent of the health workers in Kudus, amounting to around 6,000 people, have received the first and second doses of vaccination," Badai said.

"Of this number, only 308 health workers were exposed or around 5.1 percent of the total number of health workers. Most of them have recovered and have started working again," he said.

Abdul Aziz Achyar, the director of Kudus's dr. Loekmono Hadi Regional General Hospital, said a total of 153 health workers at the hospital confirmed to have Covid-19. Only 11 people, or 7.1 percent, needed hospitalization. The other 86 (56 percent) used to be in self-isolation but now ready to work, following the rest of their colleagues who had recovered earlier.

The government's vaccination program focused on immunizing health workers first, before vaccinating workers in the services industry, civil servants, and the elderly. The government will start nationwide vaccination for the general population next month, although several provinces, like Jakarta, had done so last week.

In an attempt to stem the Covid-19 spike in Kudus, the Ministry of Health has dropped 50,000 doses of the Covid-19 vaccine to accelerate vaccination coverage in the region.

"For now, we have intensified mass vaccinations in Kudus so that later we can slow down the transmission of Covid-19," H.M. Hartopo, Kudus district head, said.

Hartopo said the spike in Covid-19 cases started with homecomers returning to Kudus.

"We need to inform people that people should not ignore health protocols even though they have been vaccinated. The vaccination itself is actually only a means of increasing immunity. So that if exposed to Covid-19, there are no severe symptoms," he said.

Whatever Sinovac or Sinopharm is less effective...

I think we should see the fact from the daily new infection report from countries that use Sinovac/Sinopharm, compare it with countries that use Pfizer/Moderna.

Countries like Bahrain, Chile, and Uruguay that are using Sinopharm, see a significant drop in daily new infections. As well as Kudus case above.

Based on my own research, the result is mixed for countries that use Pfizer.

Germany saw a significant drop down to just hundreds of new cases daily, while Netherland there's a sudden spike up to 9000 new cases daily.

This is a big question to me.

If inactivated vaccine works as good as mRNA vaccine, why not?

I think we need more unbiased article, Western mainstream media full of stupid propaganda.
 
.
Whatever Sinovac or Sinopharm is less effective...

I think we should see the fact from the daily new infection report from countries that use Sinovac/Sinopharm, compare it with countries that use Pfizer/Moderna.

Countries like Bahrain, Chile, and Uruguay that are using Sinopharm, see a significant drop in daily new infections. As well as Kudus case above.

Based on my own research, the result is mixed for countries that use Pfizer.

Germany saw a significant drop down to just hundreds of new cases daily, while Netherland there's a sudden spike up to 9000 new cases daily.

This is a big question to me.

If inactivated vaccine works as good as mRNA vaccine, why not?

I think we need more unbiased article, Western mainstream media full of stupid propaganda.

China's Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses
by Noah Higgins-Dunn|
Jul 12, 2021 11:30am
coronavirus vaccine

Gavi, the vaccine alliance, said it inked supply agreements with China's Sinovac and Sinopharm worth up to 550 million doses for the vaccine sharing program COVAX. (nevodka/iStock/Getty Images Plus/Getty Images)

COVAX, the global COVID-19 vaccine sharing program, has fallen behind in its pursuit to provide poorer nations with billions of doses by year’s end. But now, the program is getting a much-needed boost from Chinese vaccine developers Sinovac and Sinopharm.

In a boon to poorer countries with lagging vaccine rollouts, Gavi, the vaccine alliance, inked supply agreements with the two drugmakers worth up to 550 million doses. Since the shots have already scored the WHO’s emergency use backing, they’ll be able to ship out immediately, Gavi said.
Sinovac has agreed to supply up to 380 million doses while Sinopharm has proffered up to 170 million. The pair will ship 110 million shots immediately through COVAX, which Gavi co-leads alongside the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).

RELATED: Sinovac aims to pump out 2B COVID-19 vaccine doses a year, courtesy of 3rd production line

Some countries, however, have recently grown concerned about the effectiveness of the two jabs, especially amid the rapid rise of virus variants. In Thailand, over 600 medical workers inoculated with Sinovac’s shot, dubbed CoronaVac, were later infected with COVID-19, Reuters reports, citing government data from April to July.
Following those infections, Thailand became the first country on Monday to say it will use AstraZeneca’s vaccine as a second dose for those who received a first jab of Sinovac’s shot, according to the news agency. A spokesperson for the company wasn’t immediately available to comment.
The move, the first to mix-and-match a Western-developed jab with a Chinese shot, is intended to boost immunity against the troublesome delta variant, first found in India, officials said. Among some of the most vaccinated countries currently experiencing outbreaks, most have relied on vaccines from Sinovac and Sinopharm, according to a new CNBC analysis.
Gavi told Fierce Pharma that it follows the WHO's endorsements in regard to vaccine effectiveness and safety. All WHO-backed shots, including Sinovac and Sinopharm, have proven to be highly effective against severe disease, hospitalization and death, a spokesperson said.

"This is even more urgent as the world confronts the rising threat of variants," Gavi said.
The group’s latest deal, which didn’t disclose a price or which countries would receive doses first, comes as global health officials repeatedly chastise rich nations for vaccinating their entire populations before at-risk groups in other countries.

The COVAX vaccination scheme has been hobbled by rich nations snapping up supplies and delays stemming from India, which is the facility’s largest provider. Those roadblocks recently pushed COVAX to bump back its goal of vaccinating 2 billion people by the end of 2021 to the first half of next year. So far, the program has shipped out just 102 million doses.

But COVAX is confident it can hit its newest goal thanks to recent donations from richer nations, as well as deals with manufacturers, Gavi said. The program’s portfolio of vaccines now totals 11, including those from Moderna, Johnson & Johnson, Pfizer-BioNTech and AstraZeneca. Last month, G7 countries pledged 870 million shots for COVAX distribution.
 
.
China's Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses
by Noah Higgins-Dunn|
Jul 12, 2021 11:30am
coronavirus vaccine

Gavi, the vaccine alliance, said it inked supply agreements with China's Sinovac and Sinopharm worth up to 550 million doses for the vaccine sharing program COVAX. (nevodka/iStock/Getty Images Plus/Getty Images)

COVAX, the global COVID-19 vaccine sharing program, has fallen behind in its pursuit to provide poorer nations with billions of doses by year’s end. But now, the program is getting a much-needed boost from Chinese vaccine developers Sinovac and Sinopharm.

In a boon to poorer countries with lagging vaccine rollouts, Gavi, the vaccine alliance, inked supply agreements with the two drugmakers worth up to 550 million doses. Since the shots have already scored the WHO’s emergency use backing, they’ll be able to ship out immediately, Gavi said.
Sinovac has agreed to supply up to 380 million doses while Sinopharm has proffered up to 170 million. The pair will ship 110 million shots immediately through COVAX, which Gavi co-leads alongside the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).

RELATED: Sinovac aims to pump out 2B COVID-19 vaccine doses a year, courtesy of 3rd production line

Some countries, however, have recently grown concerned about the effectiveness of the two jabs, especially amid the rapid rise of virus variants. In Thailand, over 600 medical workers inoculated with Sinovac’s shot, dubbed CoronaVac, were later infected with COVID-19, Reuters reports, citing government data from April to July.
Following those infections, Thailand became the first country on Monday to say it will use AstraZeneca’s vaccine as a second dose for those who received a first jab of Sinovac’s shot, according to the news agency. A spokesperson for the company wasn’t immediately available to comment.
The move, the first to mix-and-match a Western-developed jab with a Chinese shot, is intended to boost immunity against the troublesome delta variant, first found in India, officials said. Among some of the most vaccinated countries currently experiencing outbreaks, most have relied on vaccines from Sinovac and Sinopharm, according to a new CNBC analysis.
Gavi told Fierce Pharma that it follows the WHO's endorsements in regard to vaccine effectiveness and safety. All WHO-backed shots, including Sinovac and Sinopharm, have proven to be highly effective against severe disease, hospitalization and death, a spokesperson said.

"This is even more urgent as the world confronts the rising threat of variants," Gavi said.
The group’s latest deal, which didn’t disclose a price or which countries would receive doses first, comes as global health officials repeatedly chastise rich nations for vaccinating their entire populations before at-risk groups in other countries.

The COVAX vaccination scheme has been hobbled by rich nations snapping up supplies and delays stemming from India, which is the facility’s largest provider. Those roadblocks recently pushed COVAX to bump back its goal of vaccinating 2 billion people by the end of 2021 to the first half of next year. So far, the program has shipped out just 102 million doses.

But COVAX is confident it can hit its newest goal thanks to recent donations from richer nations, as well as deals with manufacturers, Gavi said. The program’s portfolio of vaccines now totals 11, including those from Moderna, Johnson & Johnson, Pfizer-BioNTech and AstraZeneca. Last month, G7 countries pledged 870 million shots for COVAX distribution.

Despite Sinovac and Sinopharm are claimed to be less effective...

It's better than without a vaccine at all.

It's like gambling, but people get a better chance with a vaccine.


I think in the future, there will be the third, fourth, fifth, and so on boosters.

The winner will be those who can release a faster booster cycle, while others are still developing the third booster, the winner is already releasing the fourth and even fifth booster to fight the latest variant.

And of course, the safer vaccine with the least side effects from each jab will win in the long run.

If the side effect from the second jab is already quite burdensome, imagine if you should take the third, the fourth, and so on. Kinda scary in my opinion.
 
.
Back
Top Bottom